{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:13Z","timestamp":1786994413042,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106771","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:55:15Z","timestamp":1758786915000},"page":"106771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neurofilament light chain levels differentiate ischemic from inflammatory optic neuropathies"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3451-0303","authenticated-orcid":false,"given":"Shailee","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-7528","authenticated-orcid":false,"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106771_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/01658107.2017.1356856","article-title":"Diffusion-weighted imaging and Post-contrast enhancement in differentiating optic neuritis and non-arteritic anterior optic neuropathy","volume":"42","author":"Adesina","year":"2018","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.msard.2025.106771_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-330412","article-title":"Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder","author":"Aktas","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106771_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0009","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106771_bib0024","first-page":"1677","article-title":"Ischemic Optic neuropathies","volume":"373","author":"Biousse","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106771_bib0016","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archopht.1996.01100140566007","article-title":"of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial","volume":"114","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106771_bib0019","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106771_bib0018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0011","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1212\/NXI.0000000000000011","article-title":"AQP4 autoantibody assay performance in clinical laboratory service","volume":"1","author":"Fryer","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106771_bib0004","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/WNO.0000000000001962","article-title":"Myelin oligodendrocyte glycoprotein-related optic neuritis and chiasmitis mimicking nonarteritic anterior ischemic optic neuropathy","volume":"44","author":"Handzic","year":"2024","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.msard.2025.106771_bib0001","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis","volume":"125","author":"Jitprapaikulsan","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2025.106771_bib0022","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0007","article-title":"Serum neurofilament light chain in NMOSD and related disorders: comparison according to Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies status","volume":"3","author":"Mariotto","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2025.106771_bib0029","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/jnnp-2018-320287","article-title":"Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders","volume":"90","author":"Mariotto","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106771_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116986","article-title":"Serum neurofilament light chain studies in neurological disorders, hints for interpretation","volume":"416","author":"Mariotto","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106771_bib0023","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s00415-019-09477-9","article-title":"Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction","volume":"266","author":"Pedersen","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/08820538.2015.1115248","article-title":"Non-arteritic anterior ischemic optic neuropathy (NAION): a review and update on animal models","volume":"31","author":"Peeler","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106771_bib0025","article-title":"The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies","volume":"2012","author":"Petzold","year":"2012","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.msard.2025.106771_bib0008","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/STROKEAHA.120.031482","article-title":"Serum neurofilament to Magnetic resonance imaging lesion area ratio differentiates spinal cord infarction from acute myelitis","volume":"52","author":"Sechi","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.msard.2025.106771_bib0012","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","article-title":"Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing","volume":"78","author":"Sechi","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1209749","article-title":"Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders","volume":"14","author":"Takai","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0028","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000737","article-title":"Serum neurofilament light chain and optical coherence tomography measures in MS: a longitudinal study","author":"Tavazzi","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106771_bib0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106771_bib0010","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","article-title":"Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke","volume":"91","author":"Tiedt","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106771_bib0006","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200214","article-title":"Acute optic neuropathy in older adults: differentiating between MOGAD optic neuritis and nonarteritic anterior ischemic optic neuropathy","volume":"11","author":"Tisavipat","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106771_bib0021","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1161\/STROKEAHA.119.026410","article-title":"NfL (Neurofilament Light Chain) levels as a predictive marker for long-term outcome after ischemic stroke","volume":"50","author":"Uphaus","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.msard.2025.106771_bib0027","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106771_bib0013","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106771_bib0003","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/WNO.0000000000001795","article-title":"Myelin oligodendrocyte glycoprotein optic neuritis mimicking nonarteritic anterior ischemic optic neuropathy","volume":"44","author":"Zapletal","year":"2024","journal-title":"J. Neuroophthalmol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:29:54Z","timestamp":1784345394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S2211034825005139"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106771","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain levels differentiate ischemic from inflammatory optic neuropathies","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106771"}}